Details

Title
Author Correction: Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities
Author
Bateman, Nicholas W. 1   VIAFID ORCID Logo  ; Abulez, Tamara 2   VIAFID ORCID Logo  ; Soltis, Anthony R. 3 ; McPherson, Andrew 4 ; Choi, Seongmin 4 ; Garsed, Dale W. 5   VIAFID ORCID Logo  ; Pandey, Ahwan 6 ; Tian, Chunqiao 2 ; Hood, Brian L. 2 ; Conrads, Kelly A. 2 ; Teng, Pang-ning 2   VIAFID ORCID Logo  ; Oliver, Julie 2 ; Gist, Glenn 2 ; Mitchell, Dave 2 ; Litzi, Tracy J. 2 ; Tarney, Christopher M. 7 ; Crothers, Barbara A. 8 ; Mhawech-Fauceglia, Paulette 9 ; Dalgard, Clifton L. 3   VIAFID ORCID Logo  ; Wilkerson, Matthew D. 3 ; Pierobon, Mariaelena 10   VIAFID ORCID Logo  ; Petricoin, Emanuel F. 10 ; Yan, Chunhua 11 ; Meerzaman, Daoud 11 ; Bodelon, Clara 12   VIAFID ORCID Logo  ; Wentzensen, Nicolas 12 ; Lee, Jerry S. H. 13   VIAFID ORCID Logo  ; Makohon-Moore, Sasha C. 2 ; Barakat, Waleed 2 ; Zhang, Xijun 3 ; Hunt, Allison 14 ; Ao, Wei 2 ; Lytle-Gabbin, Stacey L. 14 ; Casablanca, Yovanni 7 ; Hamilton, Chad A. 7 ; Newell, Miranda 14 ; Wells, Justin 15 ; Sukumar, Gauthaman 3 ; Bacikova, Dagmar 3 ; Freyman, John 16 ; Cohn, David E. 17 ; Berchuck, Andrew 18 ; Havrilesky, Laura 18 ; Duska, Linda 19 ; Odunsi, Adekunle 20 ; Sood, Anil 21 ; Brenton, James 22 ; Sala, Evis 22 ; Annunziata, Christina 23 ; Dorigo, Oliver 24 ; Nelson, Brad 25 ; Cochrane, Dawn R. 25 ; Moore, Kathleen 26 ; Baldelli, Elisa 10 ; Chen, Qing-rong 11 ; Hu, Ying 11 ; Fereday, Sian 27 ; Traficante, Nadia 27 ; DeFazio, Anna 28 ; Goode, Ellen L. 29 ; Huntsman, David G. 30 ; Shah, Sohrab 4   VIAFID ORCID Logo  ; Shriver, Craig D. 15   VIAFID ORCID Logo  ; Phippen, Neil T. 7 ; Darcy, Kathleen M. 1   VIAFID ORCID Logo  ; Bowtell, David D. L. 5 ; Conrads, Thomas P. 31   VIAFID ORCID Logo  ; Maxwell, G. Larry 31 

 Uniformed Services University of the Health Sciences, Gynecologic Cancer Center of Excellence, Gynecologic Surgery and Obstetrics, Bethesda, USA (GRID:grid.265436.0) (ISNI:0000 0001 0421 5525); The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc, Bethesda, USA (GRID:grid.201075.1) (ISNI:0000 0004 0614 9826); Uniformed Services University and Walter Reed National Military Medical Center, The John P. Murtha Cancer Center Research Program, Department of Surgery, Bethesda, USA (GRID:grid.414467.4) (ISNI:0000 0001 0560 6544) 
 Uniformed Services University of the Health Sciences, Gynecologic Cancer Center of Excellence, Gynecologic Surgery and Obstetrics, Bethesda, USA (GRID:grid.265436.0) (ISNI:0000 0001 0421 5525); The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc, Bethesda, USA (GRID:grid.201075.1) (ISNI:0000 0004 0614 9826) 
 Uniformed Services University of the Health Sciences, The American Genome Center, Collaborative Health Initiative Research Program, Department of Anatomy, Physiology and Genetics, Bethesda, USA (GRID:grid.265436.0) (ISNI:0000 0001 0421 5525) 
 Memorial Sloan Kettering Cancer Center, Department of Computational Oncology, Manhattan, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952) 
 Parkville, Peter MacCallum Cancer Centre, Melbourne, Australia (GRID:grid.1055.1) (ISNI:0000 0004 0397 8434); The University of Melbourne, Sir Peter MacCallum Department of Oncology, Parkville, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X) 
 Parkville, Peter MacCallum Cancer Centre, Melbourne, Australia (GRID:grid.1055.1) (ISNI:0000 0004 0397 8434) 
 Uniformed Services University of the Health Sciences, Gynecologic Cancer Center of Excellence, Gynecologic Surgery and Obstetrics, Bethesda, USA (GRID:grid.265436.0) (ISNI:0000 0001 0421 5525) 
 National Capital Region Medical Directorate, The Joint Pathology Center, Defense Health Agency, Silver Spring, USA (GRID:grid.478868.d) (ISNI:0000 0004 5998 2926) 
 University of Southern California, Department of Anatomic Pathology, Division of Gynecologic Pathology, Los Angeles, USA (GRID:grid.42505.36) (ISNI:0000 0001 2156 6853) 
10  George Mason University, Center for Applied Proteomics and Molecular Medicine, Manassas, USA (GRID:grid.22448.38) (ISNI:0000 0004 1936 8032) 
11  National Cancer Institute, Center for Biomedical Informatics and Information Technology, Rockville, USA (GRID:grid.48336.3a) (ISNI:0000 0004 1936 8075) 
12  Division of Cancer Epidemiology and Genetics National Cancer Institute, Rockville, USA (GRID:grid.48336.3a) 
13  University of Southern California, Ellison Institute for Transformative Medicine, Los Angeles, USA (GRID:grid.42505.36) (ISNI:0000 0001 2156 6853) 
14  Uniformed Services University of the Health Sciences, Gynecologic Cancer Center of Excellence, Gynecologic Surgery and Obstetrics, Bethesda, USA (GRID:grid.265436.0) (ISNI:0000 0001 0421 5525); Women’s Service Line, Inova Health System, Women’s Health Integrated Research Center, Falls Church, USA (GRID:grid.414629.c) (ISNI:0000 0004 0401 0871) 
15  Uniformed Services University and Walter Reed National Military Medical Center, The John P. Murtha Cancer Center Research Program, Department of Surgery, Bethesda, USA (GRID:grid.414467.4) (ISNI:0000 0001 0560 6544) 
16  National Cancer Institute, The Cancer Imaging Archive, Bethesda, USA (GRID:grid.48336.3a) (ISNI:0000 0004 1936 8075) 
17  The Ohio State University, Columbus, USA (GRID:grid.261331.4) (ISNI:0000 0001 2285 7943) 
18  Duke University Medical Center, Durham, USA (GRID:grid.189509.c) (ISNI:0000 0001 0024 1216) 
19  University of Virginia, Charlottesville, USA (GRID:grid.27755.32) (ISNI:0000 0000 9136 933X) 
20  University of Chicago, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822) 
21  MD Anderson Comprehensive Cancer Center, Houston, USA (GRID:grid.240145.6) (ISNI:0000 0001 2291 4776) 
22  University of Cambridge, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000 0001 2188 5934) 
23  National Cancer Institute, Bethesda, USA (GRID:grid.48336.3a) (ISNI:0000 0004 1936 8075) 
24  Stanford University, Stanford, USA (GRID:grid.168010.e) (ISNI:0000 0004 1936 8956) 
25  British Columbia Cancer Research Centre, Vancouver, Canada (GRID:grid.248762.d) (ISNI:0000 0001 0702 3000) 
26  University of Oklahoma Health Sciences Center, Oklahoma City, USA (GRID:grid.266902.9) (ISNI:0000 0001 2179 3618) 
27  Peter MacCallum Cancer Centre, The Australian Ovarian Cancer Study Group, Melbourne, Australia (GRID:grid.1055.1) (ISNI:0000 0004 0397 8434) 
28  The Westmead Institute for Medical Research, Sydney, Australia (GRID:grid.452919.2) (ISNI:0000 0001 0436 7430); Westmead Hospital, Department of Gynaecological Oncology, Sydney, Australia (GRID:grid.413252.3) (ISNI:0000 0001 0180 6477); The University of Sydney, Sydney, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X) 
29  Mayo Clinic, Rochester, USA (GRID:grid.66875.3a) (ISNI:0000 0004 0459 167X) 
30  The University of British Columbia, Department of Pathology and Laboratory Medicine, Vancouver, Canada (GRID:grid.17091.3e) (ISNI:0000 0001 2288 9830) 
31  Uniformed Services University of the Health Sciences, Gynecologic Cancer Center of Excellence, Gynecologic Surgery and Obstetrics, Bethesda, USA (GRID:grid.265436.0) (ISNI:0000 0001 0421 5525); Uniformed Services University and Walter Reed National Military Medical Center, The John P. Murtha Cancer Center Research Program, Department of Surgery, Bethesda, USA (GRID:grid.414467.4) (ISNI:0000 0001 0560 6544); Women’s Service Line, Inova Health System, Women’s Health Integrated Research Center, Falls Church, USA (GRID:grid.414629.c) (ISNI:0000 0004 0401 0871) 
Pages
97
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
ISSN
2397768X
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3051220622
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.